ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 34 filers reported holding ZOSANO PHARMA CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $45,000 | -52.1% | 199,497 | 0.0% | 0.00% | – |
| Q4 2021 | $94,000 | -34.7% | 199,497 | 0.0% | 0.00% | – |
| Q3 2021 | $144,000 | -24.2% | 199,497 | 0.0% | 0.00% | – |
| Q2 2021 | $190,000 | -23.1% | 199,497 | 0.0% | 0.00% | – |
| Q1 2021 | $247,000 | +263.2% | 199,497 | +53.5% | 0.00% | – |
| Q4 2020 | $68,000 | -64.8% | 129,940 | +9.3% | 0.00% | – |
| Q3 2020 | $193,000 | +124.4% | 118,881 | +17.9% | 0.00% | – |
| Q2 2020 | $86,000 | +196.6% | 100,814 | +93.0% | 0.00% | – |
| Q1 2020 | $29,000 | +16.0% | 52,238 | +221.4% | 0.00% | – |
| Q4 2019 | $25,000 | 0.0% | 16,252 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -52.8% | 16,252 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | -32.1% | 16,252 | 0.0% | 0.00% | – |
| Q1 2019 | $78,000 | +32.2% | 16,252 | -41.7% | 0.00% | – |
| Q4 2018 | $59,000 | -48.2% | 27,891 | 0.0% | 0.00% | – |
| Q3 2018 | $114,000 | -4.2% | 27,891 | -4.3% | 0.00% | – |
| Q2 2018 | $119,000 | – | 29,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 1,172,542 | $1,900,000 | 1.90% |
| Aisling Capital Management LP | 2,718,226 | $4,404,000 | 1.41% |
| Telemetry Investments, L.L.C. | 239,830 | $389,000 | 0.84% |
| Sio Capital Management, LLC | 452,542 | $733,000 | 0.14% |
| AJ WEALTH STRATEGIES, LLC | 136,476 | $221,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 453,168 | $734,000 | 0.02% |
| Highlander Capital Management, LLC | 10,000 | $16,000 | 0.01% |
| Qube Research & Technologies Ltd | 427,894 | $693,000 | 0.01% |
| Alyeska Investment Group, L.P. | 295,953 | $479,000 | 0.01% |
| WINTON GROUP Ltd | 120,182 | $195,000 | 0.01% |